TLT-1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

59,485 results for “TLT-1”

Trials

View all 35431 →

Not yet recruiting

MicroPulse TLT - UK Study

250 participants · First posted Oct 25, 2022

Time-limited Trials in the Emergency Department

40 participants · First posted Apr 22, 2024

Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy

88 participants · First posted Apr 12, 2016

Drugs

View all 7511 →

Investigational

Nangibotide

TLT-101

TLT35

Organizations

View all 1393 →

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

News

View all 15150 →

Hemab Therapeutics Files for NASDAQ IPO to Advance Bleeding Disorder Therapies

Hemab Therapeutics Advances Bleeding Disorder Pipeline with Promising Clinical Data at ISTH 2025

Hemab Therapeutics Secures $157 Million Series C to Advance First-in-Class Treatments for Rare Bleeding Disorders

Page 1 of 5949